MedPage Today
medpagetoday.com
MedPage Today
@medpagetoday.com
Healthcare is complicated. We explain it. #MedPageToday

Reposts, likes, and comments are not endorsements.
An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting early hepatocellular carcinoma (HCC), according to a prospective study. #TLM25
www.medpagetoday.com/meetingcover...
Blood Test May Be a 'Viable Alternative' in Liver Cancer Surveillance
Investigational multi-target test more sensitive than ultrasound, but fell short in specificity
www.medpagetoday.com
November 14, 2025 at 8:07 PM
Seladelpar (Livdelzi) provided sustained pruritus relief for up to 30 months in patients with primary biliary cholangitis (PBC), according to long-term data from the open-label ASSURE study. #TLM25
www.medpagetoday.com/meetingcover...
Seladelpar Eases PBC-Related Itch for 30 Months
Majority of patients achieve meaningful pruritus relief, according to long-term ASSURE data
www.medpagetoday.com
November 14, 2025 at 8:07 PM
Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study from Japan. #TLM25
www.medpagetoday.com/meetingcover...
After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk
Patients with liver fibrosis FIB-4 scores of 1.45 or more were at significantly greater risk
www.medpagetoday.com
November 14, 2025 at 8:07 PM
A dual intervention using lactulose and virtual tai chi significantly reduced falls and related harms in patients with cirrhosis and portal hypertension, according to results from the LIVE-SMART trial. #TLM25 www.medpagetoday.com/meetingcover...
Falls Drop Sharply With Lactulose, Tai Chi Combo in Cirrhosis Trial
Dual intervention outperformed usual care in reducing falls, injury risk
www.medpagetoday.com
November 14, 2025 at 8:07 PM
Long-term results from trials of new drugs for hereditary angioedema (HAE) continue to support efficacy and safety, researchers reported at the American College of Allergy, Asthma & Immunology meeting.
www.medpagetoday.com/meetingcover...
Hereditary Angioedema Pipeline Holding Up Long-Term
Phase II and III trial patients followed over 1 to 4 years show safety, efficacy
www.medpagetoday.com
November 12, 2025 at 6:53 PM
With new guidelines for the treatment of moderate to severe asthma, experts noted a shift toward increasing caution in corticosteroid use.
www.medpagetoday.com/meetingcover...
Does the Future of Asthma Treatment Involve Fewer Corticosteroids?
Risks are becoming increasingly clear
www.medpagetoday.com
November 12, 2025 at 6:53 PM
Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with MASLD and PCOS, the primary analysis of a small randomized phase IIa trial showed.
www.medpagetoday.com/meetingcover...
Saroglitazar for MASLD Cuts Liver Fat in Women With Polycystic Ovary Syndrome
And no significant changes observed in markers of ovarian function
www.medpagetoday.com
November 12, 2025 at 6:45 PM